Search

everythinglearnresearchcommunity

for

Search:↓

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Obesity can cause various skin problems, with differences in prevalence between males and females.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

DHT, a testosterone byproduct, causes male pattern baldness.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Women with PCOS often have more sleep problems than the general population.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Antiandrogen therapy helps treat genetic hair loss.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

The document explains various skin conditions and their treatments.

Metformin is safe in early pregnancy for women with PCOS and may reduce certain risks.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.